| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/14/1994 | WO1994007504A1 New pharmaceutical formulations of spiramycine |
| 04/14/1994 | WO1994007503A1 Enteric preparations |
| 04/14/1994 | WO1994007494A1 Oral compositions containing 1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxyaldehyde-o-methyl-oxime |
| 04/14/1994 | WO1994007493A1 Stabilized compositions containing 1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxyaldehyde-o-methyl-oxime |
| 04/14/1994 | WO1994007488A1 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
| 04/14/1994 | WO1994007484A1 Pharmaceutical solutions and emulsions containing taxol |
| 04/14/1994 | WO1994007478A1 Topical pharmaceutical compositions |
| 04/14/1994 | WO1994007477A1 Taste masking of thymol |
| 04/14/1994 | WO1994007476A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine |
| 04/14/1994 | WO1994007473A1 CONTROLLED-pH FORMULATION FOR INTRAVESICULAR INSTILLATION OF TGFαPE40ab |
| 04/14/1994 | WO1994007472A1 Pharmaceutical compositions containing nonionic surfactants |
| 04/14/1994 | WO1994007470A1 Article containing a core and a coating having a non constant thickness |
| 04/14/1994 | WO1994007469A1 An immunobooster for delayed release of immunogen |
| 04/14/1994 | WO1994007468A1 Two-phase matrix for sustained release drug delivery device |
| 04/14/1994 | WO1994007467A1 Calcium polycarbophil sprinkle |
| 04/14/1994 | WO1994007466A1 Compositions for treatmewnt of inflamed tissues |
| 04/14/1994 | WO1994007449A1 Transfer process for making transdermal therapeutic systems |
| 04/14/1994 | WO1994007373A1 Surface treatment composition |
| 04/14/1994 | WO1994004159A3 Treatment of cancer with azt and alkylating or intercalating agents |
| 04/14/1994 | DE4319492A1 Dicarbonsäureester Dicarboxylic |
| 04/14/1994 | CA2146572A1 Controlled-ph formulation for intravesicular instillation of tgfpe40 ab |
| 04/14/1994 | CA2146545A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine |
| 04/14/1994 | CA2146448A1 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
| 04/14/1994 | CA2146324A1 Pharmaceutical composition for the site-specific release of clot-dissolving protein and method for the preparation thereof |
| 04/14/1994 | CA2146251A1 New pharmaceutical spiramycin formulations |
| 04/14/1994 | CA2146163A1 Heterocyclic amines calmodulin antagonist properties |
| 04/14/1994 | CA2145763A1 Pharmaceutical compositions containing nonionic surfactants |
| 04/14/1994 | CA2145418A1 Pulmonary delivery of active fragments of parathyroid hormone |
| 04/14/1994 | CA2145391A1 Vaccines and antigenic conjugates |
| 04/14/1994 | CA2145205A1 Surface treatment composition |
| 04/14/1994 | CA2144059A1 Chitosan matrices for encapsulated cells |
| 04/14/1994 | CA2142982A1 Articles for sustained release of medications |
| 04/14/1994 | CA2142727A1 Oral compositions containing 1,2,5,6-tetrahydro-1-methyl-3- pyridinecarboxyaldehyde-o-methyl-oxime |
| 04/13/1994 | EP0592380A1 Ointment for treatment of epithelial lesions |
| 04/13/1994 | EP0592348A1 Pharmaceutical formulation comprised of polymyxin-trimethoprim and an anti-inflammatory drug for ophthalmic and optic topical use |
| 04/13/1994 | EP0592130A2 Hard capsules |
| 04/13/1994 | EP0591852A1 Product with reduces H2S-content and method for its production |
| 04/13/1994 | EP0591789A2 Protein forming a water channel and gene therefor |
| 04/13/1994 | EP0591710A1 Injection solutions containing mesna |
| 04/13/1994 | EP0591492A1 A pharmaceutical composition containing a defined lipid system |
| 04/13/1994 | EP0591452A1 Multiple emulsions and methods of preparation |
| 04/13/1994 | EP0591434A1 Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| 04/13/1994 | EP0591432A1 Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| 04/13/1994 | EP0591424A1 Extended-release form of diltiazem |
| 04/13/1994 | EP0591421A1 Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor |
| 04/13/1994 | EP0591408A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 04/13/1994 | EP0591395A1 Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron |
| 04/13/1994 | EP0591392A1 Pharmaceutical formulations of osteogenic proteins. |
| 04/13/1994 | EP0591389A1 Dosage form for a delayed drug delivery |
| 04/13/1994 | EP0591385A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 04/13/1994 | EP0591374A1 Nanoparticles based on a polyoxyethylene and polylactic acid block copolymer |
| 04/13/1994 | EP0591363A1 Pharmaceutical preparations containing torasemid |
| 04/13/1994 | EP0591346A1 Process for solubilizing difficultly soluble pharmaceutical actives |
| 04/13/1994 | EP0591331A1 Method of preparing nanoparticles. |
| 04/13/1994 | EP0591311A1 Controlled release systems and low dose androgens |
| 04/13/1994 | EP0591284A1 Carrier systems for drugs |
| 04/13/1994 | EP0591275A1 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions |
| 04/13/1994 | EP0591204A1 Pharmaceutical formulations. |
| 04/13/1994 | EP0440702B1 A pharmaceutical composition for rapid release of the active component comprising a solid dispersion and a surfactant |
| 04/13/1994 | EP0396616B1 Reduction of side effects of cancer therapy |
| 04/13/1994 | CN1085095A Inhalation and producing method thereof |
| 04/13/1994 | CN1085087A Sanitary medicine series for women |
| 04/13/1994 | CN1085084A Method for treatment and prevention of irritable bowel syndrome and pharmaceutical compositions therefor |
| 04/13/1994 | CN1085082A Vitamin E drop |
| 04/13/1994 | CN1085081A Pharmaceutical and other dosage forms |
| 04/13/1994 | CN1085080A Medicinal liquor |
| 04/13/1994 | CN1085079A Antithyroid cream for external application |
| 04/12/1994 | US5302706 Senescent cell derived inhibitors of DNA synthesis |
| 04/12/1994 | US5302693 Polymerizing lactide with the concurrent addition of 5-40% by weight of Polylactic Acid |
| 04/12/1994 | US5302629 Bandages, transdermal drug delivery |
| 04/12/1994 | US5302401 Method to reduce particle size growth during lyophilization |
| 04/12/1994 | US5302400 Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids |
| 04/12/1994 | US5302399 Slow-releasing pharmaceuticals prepared with alginic acid |
| 04/12/1994 | US5302398 Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids |
| 04/12/1994 | US5302397 Polymer-based drug delivery system |
| 04/12/1994 | US5302396 Superior tasting composition having porous particles and the process of preparing such pharmaceutical composition |
| 04/12/1994 | US5302395 Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes |
| 04/12/1994 | US5302394 Dextromethorphan continuous lozenge manufacturing process |
| 04/12/1994 | US5302389 Topically administering liposome encapsulated endonuclease |
| 04/12/1994 | US5302376 Cosmetic screening emulsion comprising a UV-A screening agent and a UV-B screening agent and its use for skin protection against ultraviolet radiation |
| 04/12/1994 | US5302374 Containing hydrogen peroxide |
| 04/12/1994 | US5302369 Microspheres for radiation therapy |
| 04/12/1994 | US5302172 Method and composition for iontophoresis |
| 04/12/1994 | US5301664 Methods and apparatus for drug delivery using supercritical solutions |
| 04/12/1994 | CA1328405C Pharmaceutical composition |
| 04/12/1994 | CA1328403C Therapeutic system for sparingly soluble active ingredients |
| 04/12/1994 | CA1328402C Somatostatins |
| 04/12/1994 | CA1328401C Diabetic control by combined insulin forms |
| 04/08/1994 | CA2107647A1 Supply of biologically beneficial substances to ruminant animals |
| 04/07/1994 | DE4233625A1 New animal bait for admin. of pharmaceuticals to wild animals - contains solid polymer, specific attractant and pharmaceutical active agent |
| 04/07/1994 | DE4232978A1 Prodn. of drug-contg. microparticles - with taste-masking or pH-dependent release properties |
| 04/06/1994 | EP0591048A1 Cigarette filter for the administration of taurine by inhalation |
| 04/06/1994 | EP0590963A1 Method and apparatus for preparation of a moulded tablet and a tablet prepared thereby |
| 04/06/1994 | EP0590786A1 Use of certain anionic surfactants to enhance antimicrobial effectiveness of opthalmic compositions |
| 04/06/1994 | EP0590655A1 Muco-adhesive polymers |
| 04/06/1994 | EP0590531A1 Antithrombin III preparation |
| 04/06/1994 | EP0590382A1 Method to produce pellets containing an ephedrine derivative |
| 04/06/1994 | EP0589934A1 Cosmetic or pharmaceutical, particularly dermatological, composition containing a prunella extract. |
| 04/06/1994 | EP0589883A1 Encapsulated antiperspirant salts and deodorant/antiperspirants |
| 04/06/1994 | EP0589871A1 Peritoneal induced medicaments |